Breaking News

Financial Report: Neuland Laboratories Ltd.

Revenues increased 14.5%, posted profit in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Neuland Laboratories FY 1Q12

1Q Revenues: $23.2 million (+15%)

1Q Earnings: $0.2 million (loss of $1.1 million 1Q FY11)

Comments: Growth in the quarter was driven by the company’s products and services from its API, contract research, manufacturing, and peptides synthesis businesses.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters